Institutional Ownership Ascendis Pharma A/S (ASND)
This table provides information about the institutional ownership of Ascendis Pharma A/S (ASND). We have compiled data on the 236 institutions that hold shares in the stock, with a total of 60.2 Million shares, which have been reported (via 13F filing form) to have a value of $9.05 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Ra Capital Management, L.P.
Boston, MA |
Feb 14, 2025 Q4 2024 |
10,112,744
shares
|
$1.54 Billion
22.55% of portfolio
|
Q4 2024
Added 4.14%
|
|
Westfield Capital Management CO LP
Boston, MA |
Feb 11, 2025 Q4 2024 |
5,528,239
shares
|
$842 Million
3.52% of portfolio
|
Q4 2024
Added 7.68%
|
|
Avoro Capital Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
5,103,055
shares
|
$777 Million
10.24% of portfolio
|
Q4 2024
Added 2.29%
|
|
Artisan Partners Limited Partnership
Milwaukee, WI |
Feb 12, 2025 Q4 2024 |
4,450,420
shares
|
$678 Million
0.98% of portfolio
|
Q4 2024
Added 0.89%
|
|
Janus Henderson Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
4,380,382
shares
|
$667 Million
0.32% of portfolio
|
Q4 2024
Added 4.63%
|
|
Capital International Investors
Los Angeles, CA |
Feb 13, 2025 Q4 2024 |
2,863,249
shares
|
$436 Million
0.08% of portfolio
|
Q4 2024
Added 35.74%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
2,725,546
shares
|
$415 Million
0.23% of portfolio
|
Q4 2024
Added 54.42%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
2,283,207
shares
|
$348 Million
0.04% of portfolio
|
Q4 2024
Added 7.64%
|
|
Massachusetts Financial Services CO
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,867,551
shares
|
$284 Million
0.09% of portfolio
|
Q4 2024
Added 0.03%
|
|
Franklin Resources Inc
San Mateo, CA |
Feb 12, 2025 Q4 2024 |
1,356,417
shares
|
$207 Million
0.05% of portfolio
|
Q4 2024
Reduced 7.08%
|
|
Invesco Ltd.
Atlanta, GA |
Feb 13, 2025 Q4 2024 |
1,156,013
shares
|
$176 Million
0.03% of portfolio
|
Q4 2024
Reduced 0.54%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
895,984
shares
|
$136 Million
0.02% of portfolio
|
Q4 2024
Added 34.95%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
825,761
shares
|
$126 Million
0.01% of portfolio
|
Q4 2024
Added 164.25%
|
|
Camber Capital Management LP
Boston, MA |
Feb 14, 2025 Q4 2024 |
800,000
shares
|
$122 Million
2.55% of portfolio
|
Q4 2024
Added 14.29%
|
|
Fil LTD
Hamilton, D0 |
Feb 13, 2025 Q4 2024 |
729,275
shares
|
$111 Million
0.1% of portfolio
|
Q4 2024
Added 13.9%
|
|
Putnam Investments LLC
Boston, MA |
Feb 14, 2024 Q4 2023 |
725,651
shares
|
$111 Million
0.13% of portfolio
|
Q4 2023
Reduced 6.05%
|
|
Wellington Management Group LLP
Boston, MA |
Feb 12, 2025 Q4 2024 |
704,175
shares
|
$107 Million
0.02% of portfolio
|
Q4 2024
Reduced 44.18%
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Feb 14, 2025 Q4 2024 |
702,561
shares
|
$107 Million
0.03% of portfolio
|
Q4 2024
Added 4.9%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
530,417
shares
|
$80.8 Million
0.01% of portfolio
|
Q4 2024
Added 8.17%
|
|
Vestal Point Capital, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
520,000
shares
|
$79.2 Million
4.24% of portfolio
|
Q4 2024
Added 108.0%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Feb 14, 2025 Q4 2024 |
503,669
shares
|
$76.7 Million
0.16% of portfolio
|
Q4 2024
Added 1.64%
|
|
Alliancebernstein L.P.
New York, NY |
Feb 12, 2025 Q4 2024 |
445,028
shares
|
$67.8 Million
0.02% of portfolio
|
Q4 2024
Reduced 2.15%
|
|
American Century Companies Inc
Kansas City, MO |
Feb 11, 2025 Q4 2024 |
407,294
shares
|
$62 Million
0.03% of portfolio
|
Q4 2024
Added 17.46%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
405,989
shares
|
$61.8 Million
0.0% of portfolio
|
Q2 2024
Added 0.2%
|
|
Groupama Asset Managment
Paris, I0 |
Feb 12, 2025 Q4 2024 |
400,000
shares
|
$60.9 Million
0.01% of portfolio
|
Q4 2024
Reduced 0.99%
|